A photoresponsive antibody–siRNA conjugate for activatable immunogene therapy of cancer
Sign Up to like & getrecommendations! Published in 2022 at "Chemical Science"
DOI: 10.1039/d2sc01672a
Abstract: Tumor-targeted delivery of small-interfering RNAs (siRNAs) for cancer therapy still remains a challenging task. While antibody–siRNA conjugates (ARCs) provide an alternative way to address this challenge, the uncontrollable siRNA release potentially leads to undesirable off-tumor… read more here.
Keywords: immunogene therapy; therapy; photoresponsive antibody; cancer ... See more keywords